ICU Medical Q1 2021 Earnings Report
Key Takeaways
ICU Medical reported first quarter 2021 results with revenue of $318.0 million, a decrease compared to $328.6 million in the same period last year. GAAP net income was $23.7 million, or $1.09 per diluted share, compared to $16.8 million, or $0.78 per diluted share, for the first quarter of 2020. Adjusted diluted earnings per share were $1.62, as compared to $1.81 for the first quarter of 2020.
First quarter revenue was $318.0 million, compared to $328.6 million in the same period last year.
GAAP gross profit was $112.7 million, compared to $121.4 million in the same period last year.
GAAP net income was $23.7 million, or $1.09 per diluted share, compared to $16.8 million, or $0.78 per diluted share, for the first quarter of 2020.
Adjusted diluted earnings per share were $1.62 as compared to $1.81 for the first quarter of 2020.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.
Revenue & Expenses
Visualization of income flow from segment revenue to net income